Echo Therapeutics(美國)

Echo Therapeutics

,EchoTherapeutics,www.echotx.com成立于1989年，總部設(shè)于美國費(fèi)城，主要研發(fā)非侵入性無線透皮式動(dòng)態(tài)血糖監(jiān)測(cè)系統(tǒng)(CGM)，包括無針型Symphony CGMSystem以及用于透皮給藥的PreludeSkinPrepSystem。CGM是一種會(huì)發(fā)出微小電脈到皮膚，用感應(yīng)器檢測(cè)出血糖通過毛細(xì)血管的擴(kuò)散，使血糖讀數(shù)發(fā)送到無線手持儀器之產(chǎn)品。產(chǎn)品主要應(yīng)用于醫(yī)院中糖尿病人之 臨床的設(shè)置。EchoTherapeuticsisdevelopingtheSymphonyCGMSystemasanon-invasive,wireless,continuousglucosemonitoringsystem.Ourtargetispatientswhocouldbenefitfromglucosemonitoringinthehospitalsetting,includingcriticalcare.SignificantopportunityalsoexistsforpatientswithdiabetestouseSymphonyintheoutpatientsetting.Echoisalsodevelopingitsneedle-freeskinpreparationcomponentofSymphony,thePrelude®SkinPrepSystem,asaplatformtechnologytoenhancedrugdeliveryoftopicalpharmaceuticals.